Making The Case For Zynerba Pharmaceuticals

Making The Case For Zynerba Pharmaceuticals

Advancing science as a biotechnology company rarely goes exactly as planned, and Zynerba Pharmaceuticals (ZYNE) is no exception. When they reported data from their pivotal CONNECT-FX trial, the marke…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *